ASCO® GI 2025 Insights: Phase 1b Study of Gemcitabine & Nab-Paclitaxel in Combination With Lixumistat for Treatment-Naïve mPDAC | VuMedi

Find latest Pancreatic Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

This video is featured in the Insights from 2025 ASCO® GI Annual Meeting

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Phase 1b Study of Gemcitabine & Nab-Paclitaxel in Combination With Lixumistat for Treatment-Naïve mPDAC

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Shubham Pant

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Shubham Pant

101 views

February 3, 2025

Comments 0

Login to view comments. Click here to Login